Pfizer and BioNTech’s Covid-19 vaccine candidate shows promising efficacy

Pfizer, BioNTech’s Covid-19 vaccine candidate has showed promising efficacy in the first interim efficacy analysis of phase 3 clinical trial. (Credit: Gerd Altmann from Pixabay)